These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7927544)

  • 1. Early bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide in pulmonary tuberculosis patients.
    Paramasivan CN; Herbert D; Umapathy KC; Rahman F; Krishnamurthy PV; Prabhakar R
    Indian J Med Res; 1994 Jul; 100():1-4. PubMed ID: 7927544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide on Mycobacterium tuberculosis in vitro.
    Paramasivan CN; Herbert D; Prabhakar R
    Indian J Med Res; 1993 Jul; 97():145-50. PubMed ID: 8406638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
    Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
    S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.
    Jindani A; Doré CJ; Mitchison DA
    Am J Respir Crit Care Med; 2003 May; 167(10):1348-54. PubMed ID: 12519740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis.
    Chan SL; Yew WW; Ma WK; Girling DJ; Aber VR; Felmingham D; Allen BW; Mitchison DA
    Tuber Lung Dis; 1992 Feb; 73(1):33-8. PubMed ID: 1326348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis.
    Gillespie SH; Gosling RD; Uiso L; Sam NE; Kanduma EG; McHugh TD
    J Antimicrob Chemother; 2005 Dec; 56(6):1169-71. PubMed ID: 16223939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis.
    Furin JJ; Du Bois J; van Brakel E; Chheng P; Venter A; Peloquin CA; Alsultan A; Thiel BA; Debanne SM; Boom WH; Diacon AH; Johnson JL
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6591-6599. PubMed ID: 27550361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis.
    Lancet; 1981 Jan; 1(8213):171-4. PubMed ID: 6109855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
    Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients.
    Diacon AH; Dawson R; Hanekom M; Narunsky K; Venter A; Hittel N; Geiter LJ; Wells CD; Paccaly AJ; Donald PR
    Int J Tuberc Lung Dis; 2011 Jul; 15(7):949-54. PubMed ID: 21682970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis.
    Donald PR; Sirgel FA; Botha FJ; Seifart HI; Parkin DP; Vandenplas ML; Van de Wal BW; Maritz JS; Mitchison DA
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):895-900. PubMed ID: 9310010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
    Su WJ; Perng RP
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1029-32. PubMed ID: 12475151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The early bactericidal activity of amikacin in pulmonary tuberculosis.
    Donald PR; Sirgel FA; Venter A; Smit E; Parkin DP; Van de Wal BW; Mitchison DA
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):533-8. PubMed ID: 11409580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

  • 17. Bacteriological investigations for short-course chemotherapy under the tuberculosis programme in two districts of India.
    Paramasivan CN; Chandrasekaran V; Santha T; Sudarsanam NM; Prabhakar R
    Tuber Lung Dis; 1993 Feb; 74(1):23-7. PubMed ID: 8495016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.
    Burman WJ; Goldberg S; Johnson JL; Muzanye G; Engle M; Mosher AW; Choudhri S; Daley CL; Munsiff SS; Zhao Z; Vernon A; Chaisson RE
    Am J Respir Crit Care Med; 2006 Aug; 174(3):331-8. PubMed ID: 16675781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
    Sokolova GB; Koriakin VA; Khalbaeva IV; Elistratova NA; Ziia AV
    Probl Tuberk; 1993; (5):21-3. PubMed ID: 8295879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.
    Kennedy N; Fox R; Kisyombe GM; Saruni AO; Uiso LO; Ramsay AR; Ngowi FI; Gillespie SH
    Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1547-51. PubMed ID: 8256898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.